Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering.

BACKGROUND The extent to which cardiovascular disease (CVD) risk factors cluster in youth with a diagnosis of type 1 (T1DM) or type 2 diabetes mellitus (T2DM) is unclear. Therefore, we aimed to evaluate potential clustering of traditional CVD risk factors that may reflect an unmeasured but unifying single pathology that may explain the phenomenon of the metabolic syndrome in these youths. METHODS Youths who participated in the SEARCH for Diabetes in Youth study with diabetes diagnosed <20 years, with current age >10 years (maximum current age, 22 years) were included. Confirmatory factor analysis (CFA) was performed to determine statistical associations among CVD risk factors, including obesity, blood pressure, triglycerides, and high-density lipoprotein cholesterol (HDL-C). Diabetes type was defined by diabetes autoantibodies (DAA) and fasting C-peptide (FCP); type 1 (T1DM, DAA positive, and FCP <0.8 ng/mL, n = 1198) and type 2 (T2DM, DAA negative, and FCP >2.9 ng/mL, n = 95). For T1DM, the sample was split randomly and analyses were conducted separately in each split sample. RESULTS Among five prespecified data structures ranging from a single underlying factor to a hierarchical structure of factors, the worst-fitting model for both of the T1DM split samples was the single-factor structure and the best-fitting model was a three-correlated-factor structure. The three correlated factors identified were obesity, lipids, and blood pressure. Results were very similar for youths with T2DM. CONCLUSION There is little evidence that a single factor underlies the CVD risk factor pattern in youths with diabetes. The concept of the metabolic syndrome provides a useful description of clinical characteristics but does not efficiently capture a single target for etiologic research among youths with diabetes.

[1]  K. Kaski,et al.  Metabolic Phenotypes, Vascular Complications, and Premature Deaths in a Population of 4,197 Patients With Type 1 Diabetes , 2008, Diabetes.

[2]  W. Młynarski,et al.  Insulin sensitivity in Type 1 diabetic children and adolescents , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[3]  T. Orchard,et al.  The Prediction of Major Outcomes of Type 1 Diabetes: a 12-Year Prospective Evaluation of Three Separate Definitions of the Metabolic Syndrome and Their Components and Estimated Glucose Disposal Rate , 2007, Diabetes Care.

[4]  E. Oda The Metabolic Syndrome (Emperor) Wears No Clothes , 2006, Diabetes Care.

[5]  Desmond E. Williams,et al.  The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study , 2006, Pediatrics.

[6]  S. Daniels,et al.  Prevalence of Cardiovascular Disease Risk Factors in U.S. Children and Adolescents With Diabetes , 2006, Diabetes Care.

[7]  R. Niaura,et al.  A Single Factor Underlies the Metabolic Syndrome: A Confirmatory Factor Analysis , 2006, Diabetes Care.

[8]  S. Grundy Does the Metabolic Syndrome Exist? A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[9]  J. Shaw,et al.  A Single Factor Underlies the Metabolic Syndrome: A Confirmatory Factor Analysis , 2006, Diabetes Care.

[10]  G. Reaven,et al.  The metabolic syndrome: is this diagnosis necessary? , 2006, The American journal of clinical nutrition.

[11]  Sharla Montvel-Cohen "Search for diabetes in youth". , 2006, Hawaii medical journal.

[12]  N. Schneiderman,et al.  Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: the Miami Community Health Study. , 2006, Annals of epidemiology.

[13]  B. Viollet,et al.  Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. , 2006, Diabetes.

[14]  S. Grundy,et al.  Does the metabolic syndrome exist. Authors' reply , 2006 .

[15]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[16]  Laura M. Stapleton,et al.  Re: "(Mis)use of factor analysis in the study of insulin resistance syndrome". , 2005, American journal of epidemiology.

[17]  G. Reaven The metabolic syndrome: requiescat in pace. , 2005, Clinical chemistry.

[18]  S. Daniels,et al.  Factor Analysis of Clustered Cardiovascular Risks in Adolescence: Obesity Is the Predominant Correlate of Risk Among Youth , 2005, Circulation.

[19]  D. Lawlor,et al.  (Mis)use of factor analysis in the study of insulin resistance syndrome. , 2005, American journal of epidemiology.

[20]  G. Duncan,et al.  Prevalence and trends of a metabolic syndrome phenotype among u.s. Adolescents, 1999-2000. , 2004, Diabetes care.

[21]  D. Allison,et al.  Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. , 2004, The Journal of pediatrics.

[22]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[23]  Isabel Rey Madeira,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. , 2004, Pediatrics.

[24]  National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents , 2004, Pediatrics.

[25]  E. Bonora,et al.  The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[26]  SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. , 2004, Controlled clinical trials.

[27]  W. Dietz,et al.  Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. , 2003, Archives of pediatrics & adolescent medicine.

[28]  E. Bonora,et al.  Predictors of insulin sensitivity in Type 2 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[29]  Å. Lernmark,et al.  Evaluation of a novel radioimmunoassay using125I-labelled human recombinant GAD65 for the determination of glutamic acid decarboxylase (GAD65) autoantibodies , 2000, International journal of clinical & laboratory research.

[30]  Wei Chen,et al.  Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. , 1999, American journal of epidemiology.

[31]  P. Bentler,et al.  Fit indices in covariance structure modeling : Sensitivity to underparameterized model misspecification , 1998 .

[32]  R. Hoyle Structural equation modeling: concepts, issues, and applications , 1997 .

[33]  Joshua A. David,et al.  Abstract , 1996, Journal of the Neurological Sciences.

[34]  Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study. , 1992, American journal of public health.

[35]  A. Hainline,et al.  Role and methods of the central laboratory , 1983 .

[36]  A. Hainline,et al.  The Coronary Drug Project. Role and methods of the Central Laboratory. , 1983, Controlled clinical trials.

[37]  B. Barnes The Coronary Drug Project , 1972 .

[38]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.